Topical Tirbanibulin for the treatment of actinic cheilitis
Background: Actinic cheilitis (AC) is a chronic inflammatory condition that is caused by excessive exposure to ultraviolet radiation from sunlight with an increased risk of developing invasive squamous cell carcinoma. There are currently no approved topical treatments. The aim of this study was to evaluate the efficacy and tolerability of tirbanibulin as a topical treatment for AC.
Authors
- Roland Aschoff (ORCID: https://orcid.org/0000-0002-5740-8651)
- Sarah Hobelsberger (ORCID: https://orcid.org/0000-0001-5703-324X)
- Nina Günther
Institutions
- University Hospital Carl Gustav Carus (DE)
Publication Details
- Journal
- EJC Skin Cancer
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ejcskn.2025.100290
- Citations
- 1
- Primary Topic
- Autoimmune and Inflammatory Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.35